Table 2.
Turkish N = 55 n (%) |
Moroccan N = 101 n (%) |
P | Total Turkish/Moroccan N = 156 n (%) |
Comparative group N = 321 n (%) |
P | |
---|---|---|---|---|---|---|
Socio-demographic and clinical variables | ||||||
Age at diagnosis mean (SD) | 51.70 (12.61) | 47.81 (11.21) | 0.05 | 49.18 (11.83) | 61.73 (14.62) | 0.0001 |
Surgery | ||||||
BCT | 35 (66.0) | 56 (57.7) | 0.32 | 91 (60.7) | 178 (59.3) | 0.79 |
Mastectomy | 18 (34.0) | 41 (42.3) | 59 (39.3) | 122 (40.7) | ||
TNM-stage | ||||||
0–I | 41 (75.9) | 55 (56.7) | 0.02 | 96 (63.6) | 225 (74.8) | 0.01 |
II | 3 (5.6) | 20 (20.6) | 23 (15.2) | 45 (15.0) | ||
III | 7 (13.0) | 9 (56.2) | 16 (10.6) | 19 (6.3) | ||
IV | 3 (5.6) | 13 (13.4) | 16 (10.6) | 12 (4.0) | ||
Poor or no mastery of Dutch language | 28 (50.9) | 40 (39.6) | 0.17 | 68 (43.6) | 4 (1.2) | 0.0001 |
Consultation translated | 23 (41.8) | 30 (29.7) | 0.13 | 53 (34.0) | 2 (0.6) | 0.0001 |
By family | 19 (34.5) | 28 (27.7) | 47 (30.1) | 2 (0.6) | ||
≥1 time by professional | 4 (7.3) | 2 (2.0) | 6 (3.8) | (0) |
BCT breast conserving therapy, TNM tumor, nodes, metastases, TNM staging takes into account the size of the tumour (T), whether the cancer has spread to the lymph nodes (N), and whether there are metastases (M)
The TNM-stages are defined from group 0 through IV, and indicate the increasing extent of disease at the time of the initial diagnosis. Stage 0 includes breast cancer in situ, Stages I–III include different tumour sizes and lymph nodes without distant metastases, and Stage IV indicates the presence of distant metastases
* Number of respondents may vary across variables according to missing data